BA
The Boeing Company
BA has lower modeled downside risk, despite its lower overall score.
KELYB
Kelly Services, Inc.
KELYB has the edge over BA overall, supported by stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
KELYB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Healthy |
KELYB's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
KELYB PE Valuation
KELYB has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over KELYB on the outlook, with more favorable revenue expectations.
KELYB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect KELYB's earnings to grow and its profitability to improve, with its revenue holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over KELYB on earnings quality, reporting a profit while its opponent remains loss making.
KELYB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.57 | +$0.87 |
| Q2 2026 | -$7.78 | -$7.62 |
| Q1 2026 | -$7.57 | -$7.01 |
| Q4 2025 | -$7.24 | -$7.22 |
| Q3 2025 | -$4.44 | -486% |
| Q2 2025 | -$0.16 | -112% |
| Q1 2025 | -$0.56 | -140% |
| Q4 2024 | -$0.02 | -102% |
KELYB lost $3.57 per share over the past year, a smaller loss than the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over KELYB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over KELYB on profitability, with a higher operating margin.
KELYB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $927.2M | -0.8% |
| Q2 2026 | $1B | -5.8% |
| Q1 2026 | $1B | -11% |
| Q4 2025 | $1B | -12% |
| Q3 2025 | $935M | -9.9% |
| Q2 2025 | $1.1B | +4.2% |
| Q1 2025 | $1.2B | +11% |
| Q4 2024 | $1.2B | -3.3% |
KELYB's revenue has slid since its 2019 peak: $927M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.1% | +11 points |
| Q2 2026 | 1.6% | -0.5 points |
| Q1 2026 | -0.5% | -1.4 points |
| Q4 2025 | -0.1% | +4.7 points |
| Q3 2025 | -11% | -11 points |
| Q2 2025 | 2% | +0.9 points |
| Q1 2025 | 0.9% | -1.6 points |
| Q4 2024 | -4.8% | -5.3 points |
KELYB's operating margin was 0.1% last quarter, up 11 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over KELYB on cash generation, producing positive trailing cash flow while its opponent burns cash.
KELYB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$56.2M | -$28.6M |
| Q2 2026 | $47.7M | -49% |
| Q1 2026 | -$26.5M | -224% |
| Q4 2025 | $26.9M | +107% |
| Q3 2025 | -$27.6M | -$4.9M |
| Q2 2025 | $93.4M | +71% |
| Q1 2025 | $21.4M | +$50.6M |
| Q4 2024 | $13M | -68% |
KELYB's free cash flow was −$8M over the past year, against $100M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
KELYB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -500K shares |
| 1 year | -1.7% | -600K shares |
| 3 years | -3.1% | -1.1M shares |
| 5 years | -12% | -4.8M shares |
| Available history | -11% | -4.5M shares |
KELYB has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q3 2023 | $7.4M |
| Q2 2023 | $16.5M |
| Q1 2023 | $18.3M |
| Q3 2022 | — |
| Q2 2022 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
KELYB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 14.6x | High |
| Q4 2024 | 8.0x | High |
| Q3 2024 | 2.3x | Moderate |
| Q2 2024 | 2.1x | Moderate |
| Q1 2024 | -2.7x | Net Cash |
| Q4 2023 | -2.2x | Net Cash |
KELYB has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
KELYB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 64.1 | Neutral |
KELYB's weekly RSI is 56 (neutral) and its Stochastic is 64 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
KELYB PE vs Industrials Sector
| Metric | KELYB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
KELYB has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
KELYB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.0 | 2.2% below |
| 20 week MA | $23.4 | 0.4% above |
| 50 week MA | $18.1 | 30% above |
| 100 week MA | $15.4 | 53% above |
| 200 week MA | $17.5 | 34% above |
KELYB has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
KELYB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.4 | $20.2 | -5.4% |
| 2021 | $20.2 | $17.1 | -15% |
| 2022 | $17.1 | $16.5 | -3.6% |
| 2023 | $16.5 | $21.7 | +32% |
| 2024 | $21.7 | $14.0 | -35% |
| 2025 | $14.0 | $8.48 | -39% |
| 2026 YTD | $8.48 | $23.5 | +177% |
KELYB has the edge over BA on returns for 2026, with the stronger performance.